drugset / Trial / NCT00992342
A Phase 1 Study To Evaluate The Safety And Tolerability Of Different Doses Of PF-03893787 In Healthy Adult Volunteers
RandomizedParallel-groupDouble-blindBasic science
Summary
The purpose of this study is to investigate safety and toleration of multiple oral doses as well as the time course of PF-03893787 concentration in the blood following dosing by oral solution.
Timeline
- Start
- 2009-11
- Primary completion
- 2010-03
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ADRIFORANT | Small molecule | 5 mg | Oral |
| Subject | ADRIFORANT | Small molecule | 15 mg | Oral |
| Subject | ADRIFORANT | Small molecule | 50 mg | Oral |
Indications
No indication recorded.